Back

Association between high-intensity lipid-lowering therapy and atherosclerotic plaque content changes assed by iMAP-IVUS and near-infrared spectroscopy in patients with premature atherosclerosis

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Imaging in chronic coronary syndrome Angiography, Invasive Imaging ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Maris Lapsovs

Paul Stradins Clinical University Hospital, Riga (Latvia)

7 More presentations in this session

Presentation thumbnail
Prognostic value of transthoracic echocardiography in the evaluation of suspected myocardial infarction
Ms A. Schock (Hamburg, DE)
Abstract Slides Video
Presentation thumbnail
Poor prognosis of patients with acute coronary syndrome presenting optical coherence tomography-defined calcified nodule at culprit lesions after emergent percutaneous coronary intervention
Doctor M. Hada (Aalst, BE)
Abstract Slides Video
Presentation thumbnail
Coronary artery calcium assessment on routine non-gated chest CT as a gatekeeper for additional imaging in patients with stable chest pain
Miss R. Groen (Leiden, NL)
Abstract Slides Video
Presentation thumbnail
Cost-effectiveness of sequential CAC-first imaging approach for detection of coronary artery disease in comparison to SPECT-first imaging
Miss M. Kamerman (Zwolle, NL)
Abstract Slides Video
Presentation thumbnail
Intravascular ultrasonography guided percuatneous coronary intervention with everolimus-eluting stents or bypass surgery for multivessel coronary artery disease: post-hoc analysis of the BEST study
Doctor J. Lee (Seoul, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Imaging in chronic coronary syndrome

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
Inclisiran-containing low-density lipoprotein cholesterol reduction effectively stabilizes atherosclerotic plaques
thumbnail
Congress Presentation
Intensified hypolipidaemic therapy with inclisiran for atherosclerotic plaque stabilization
thumbnail
Congress Presentation
Bailout inclisiran-based triple lipid-lowering therapy reduces plaque lipid content in stable coronary artery disease patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources